ALLOHA
Live / Allowed — Second extension granted (statement of use) (as of 01 Jun 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 24 May 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98568310
- Mark type
- Word mark
- Filed
- 24 May 2024
- Published for opposition
- 15 Apr 2025
- Attorney of record
- Tiffany D. Gehrke
Goods and services
- Class 005 — Pharmaceuticals: Cells for medical or clinical use for use in the treatment of cancer; pharmaceutical and biopharmaceutical T-cell receptor engineered preparations for use in the treatment of cancer; T-cell therapy products, namely, T-cell receptor engineered cells for medical use in the treatment of cancer
- Class 042 — Scientific and technological services: Pharmaceutical research and development in the field of T-cell therapy for the treatment of cancer; T-cell therapy research services, namely, pharmaceutical and scientific research in the field of treatment of cancer using T-cell receptor engineered T-cell therapies
Owner
- TScan Therapeutics, Inc., Waltham, MA, US
- TScan Therapeutics, Inc., Waltham, MA, US
Prosecution history
- 02 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Jun 2026 — SOU EXTENSION 2 GRANTED
- 01 Jun 2026 — SOU EXTENSION 2 FILED
- 01 Jun 2026 — SOU TEAS EXTENSION RECEIVED
- 03 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Dec 2025 — SOU EXTENSION 1 GRANTED
- 02 Dec 2025 — SOU EXTENSION 1 FILED
- 02 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Apr 2025 — PUBLISHED FOR OPPOSITION
- 09 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Mar 2025 — EXAMINER'S AMENDMENT ENTERED
- 21 Mar 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED